Advent Technologies announces new CFO – Business Wire


BOSTON-(COMMERCIAL THREAD) – Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or the “Company”), an innovation-driven leader in fuel cell and hydrogen technology, today announced that Kevin Brackman has been named the new CFO. He reports to the Chairman of the Board of Directors and CEO of Advent, Dr Vasilis Gregoriou.

Mr. Brackman is a very experienced executive who most recently served as Chief Financial Officer of Myers Industries, a publicly traded company with international manufacturing and sales offices in the field of polymer manufacturing. Prior to his promotion to CFO in 2018, he was Accounting Director and Corporate Controller at Myers. Prior to joining Myers, Mr. Brackman was Director of Financial Planning and Analysis, Financial Reporting and Technical Accounting at Ingersoll-Rand. He has leadership experience in public companies and has experience in developing and improving internal control and reporting systems at all levels of an organization.

Mr. Brackman said, “I am excited about the opportunity offered by Advent and look forward to supporting the company in integrating its targeted acquisitions of Serenergy and fischer eco solutions. I plan to use the nearly thirty years of accounting and financial reporting experience I have gained to support the company in its mission to decarbonise the planet through Advent’s innovative fuel cell technology. ”

Dr. Vasilis Gregoriou, President and CEO of Advent, said, “Kevin’s solid financial and accounting background will benefit Advent and he has the expertise to help the company move into the next phase of growth. He has proven himself and I am delighted that he has decided to support our goal of providing green electricity in all energy sectors. ”

Mr. Brackman replaces Bill Hunter, who, following the merger in February 2021 with AMCI Acquisition Corp., was CFO of Advent, where he was managing director. Mr. Hunter left Advent to pursue other interests and continue his work on the Board of Directors.

“Bill’s efforts were instrumental in bringing Advent to the public market and everyone in the company wishes him luck in his future endeavors,” said Dr. Gregoriou.

Bill Hunter said, “I am very proud of the work done by the Advent team in bringing the business combination with AMCI Acquisition Corp. make it a success. Thanks to revolutionary technology and the leadership of Dr. Gregoriou and his team, the future of the company is very bright. ”

About Advent Technologies Holdings, Inc.

Advent Technologies Holdings, Inc. is an American company that designs, manufactures and assembles critical components for fuel cells and advanced energy systems in the renewable energy industry. Advent is headquartered in Boston, Massachusetts, with offices in the San Francisco Bay Area and in Europe. With more than 120 granted (or pending) patents for its fuel cell technology, Advent owns the intellectual property for next-generation High Temperature Proton Exchange Membranes (HT-PEMs), which enable various fuels to operate at high temperatures in extreme conditions – flexible “Any fuel. Somewhere.” Option for the automotive, marine, aerospace and power generation industries. For more information , go to www.advent.energie.

Caution regarding forward-looking statements

This press release contains forward-looking statements. These forward-looking statements can generally be identified by the use of words such as “anticipate”, “expect”, “,” “”, “objective”, “project” and other words with similar meanings. Any forward-looking statement contained in this press release is subject to risks and uncertainties which could cause actual results to differ materially from those expressed or implied in this statement. The applicable risks and uncertainties include, but are not limited to, the ability of the Company to realize the benefits of the business combination; the Company’s ability to maintain the Company’s common stock listing on the Nasdaq; future financial performance; Potential liquidity and trading of government securities; Effects of the outcome of a known and unknown dispute; Ability to forecast and maintain a reasonable rate of income growth and to plan expenses appropriately; Expectations for future spending; mix of future sales and impact on gross margins; Attract and retain qualified directors, officers, employees and key personnel; Ability to compete effectively in a competitive industry; Ability to protect and enhance our reputation and brand; Expectations regarding our relationships and actions with our technology partners and other third parties; The impact of future regulatory, judicial and legislative changes on the industry; Ability to locate and acquire complementary technologies or services and integrate them into the company’s activities; future agreements or investments in other companies or associations; and intense competition and pressure from other companies around the world in the sectors in which the company will operate; and the risks identified under “Risk Factors” in our annual report on Form 10-K / A filed with the Securities and Exchange Commission on May 20, 2021, and other information we file with the SEC. We caution investors not to place undue reliance on any forward-looking statements contained in this press release. We encourage you to read our SEC filings, available at, to discuss these and other risks and uncertainties. The forward-looking statements contained in this press release speak only as of the date of this document, and we assume no obligation to update or revise any such statements. Our business is subject to significant risks and uncertainties, including those mentioned above. Investors, potential investors and others should carefully consider these risks and uncertainties.


About Catriona

Check Also

Nemaura receives a provisional purchase order from Middle

LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or …

Leave a Reply

Your email address will not be published.